Establishing the phenotype in novel acute and chronic murine models of allergic asthma

International Immunopharmacology

Volumn 8, Issue 5, 2008, Pages 756-763

  Fernandez Rodriguez, Sofia ^a   Ford, William R ^a   Broadley, Kenneth J ^a   Kidd, Emma J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Acute and chronic models; Allergic asthma; In vivo; Lung function; Mouse

Indexed keywords

ALLERGEN; ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; METHACHOLINE; OVALBUMIN; SODIUM CHLORIDE;

ACUTE DISEASE; AIRWAY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE MODEL; EOSINOPHIL; EOSINOPHILIA; INFLAMMATORY CELL; INHALATION; LUNG FUNCTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ALLERGENS; ANIMALS; ANTIBODIES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTOR AGENTS; CELL COUNT; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; OVALBUMIN; PHENOTYPE; PLETHYSMOGRAPHY, WHOLE BODY; PNEUMONIA; RESPIRATORY FUNCTION TESTS;

EID: 41249095850     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.025     Document Type: Article

References (51)

1. Tattersfield A.E., Knox A.J., Britton J.R., and Hall I.P. Asthma. Lancet 360 (2002) 1313-1322
2. Wardlaw A.J., Brightling C.E., Green R., Woltmann G., Bradding P., and Pavord I.D. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 103 (2002) 201-211
3. Barnes P.J. Pathophysiology of asthma. Br J Clin Pharmacol 42 (1996) 3-10
4. Herz U., Renz H., and Wiedermann U. Animal models of type I allergy using recombinant allergens. Methods 32 (2004) 271-280
5. Kumar R.K., Herbert C., Thomas P.S., Wollin L., Beume R., Yang M., et al. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 307 (2003) 349-355
6. Postma D.S., and Kerstjens H.A.M. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 58 (1998) S187-S192
7. O'Connor B.J., Crowther S.D., Costello J.F., and Morley J. Selective airway responsiveness in asthma. Trends Pharmacol Sci 20 (1999) 9-11
8. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., and Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 56 (1998) 849-856
9. Torres R., Picado C., and de Mora F. Use of the mouse to unravel allergic asthma: a review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans. Arch Bronconeumol 41 (2005) 141-152
10. Weersink E.J., Postma D.S., Aalbers R., and de Monchy J.G. Early and late asthmatic reaction after allergen challenge. Respir Med 88 (1994) 103-114
11. Yoshida M., Watson R.M., Rerecich T., and O'Byrne P.M. Different profiles of T-cell IFN-gamma and IL-12 in allergen-induced early and dual responders with asthma. J Allergy Clin Immunol 115 (2005) 1004-1009
12. Hamid Q., Tulic M.K., Liu M.C., and Moqbel R. Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 111 (2003) S5-S17
13. Crosby J.R., Cieslewicz G., Borchers M., Hines E., Carrigan P., Lee J.J., et al. Early phase bronchoconstriction in the mouse requires allergen-specific IgG. J Immunol 168 (2002) 4050-4054
14. Picado C. Early and late-phase asthmatic reactions: a hypothesis. Allergy 47 (1992) 331-333
15. Hutson P.A., Church M.K., Clay T.P., Miller P., and Holgate S.T. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis 137 (1988) 548-557
16. Itoh K., Takahashi E., Mukaiyama O., Satoh Y., and Yamaguchi T. Relationship between airway eosinophilia and airway hyperresponsiveness in a late asthmatic model of guinea pigs. Int Arch Allergy Immunol 109 (1996) 86-94
17. Santing R.E., Olymulder C.G., Van der Molen K., Meurs H., and Zaagsma J. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 275 (1995) 75-82
18. Toward T.J., Smith N., and Broadley K.J. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. Am J Respir Crit Care Med 169 (2004) 227-234
19. Hessel E.M., Van Oosterhout A.J., Hofstra C.L., De Bie J.J., Garssen J., Van Loveren H., et al. Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol 293 (1995) 401-412
20. Smith N., and Johnson F.J. Early- and late-phase bronchoconstriction, airway hyper-reactivity and cell influx into the lungs, after 5′-adenosine monophosphate inhalation: comparison with ovalbumin. Clin Exp Allergy 35 (2005) 522-530
21. Ohkawara Y., Lei X.-F., Stampfli M.R., Marshall J.S., Xing Z., and Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 16 (1997) 510-520
22. Kumar R.K., and Foster P.S. Murine model of chronic human asthma. Immunol Cell Biol 79 (2001) 141-144
23. Platts-Mills T.A.E., Woodfolk J.A., Erwin E.A., and Aalberse R. Mechanisms to tolerance to inhaled allergens: the relevance of a modified Th2 response to allergens from domestic animals. Springer Semin Immunopathol 25 (2003) 271-279
24. Schramm C.M., Puddington L., Wu C., Guernsey L., Gharaee-Kermani M., Phan S.H., et al. Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airways disease. Am J Physiol 164 (2003) 295-304
25. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 (1997) 766-775
26. Liddell J.E., and Cryer A. A practical guide to monoclonal antibodies (1991), John Wiley & Sons Editorial, Chichester
27. Itami D.M., Latinne D., Bazin H., Garcia M.L., Perini A., Martins M.A., et al. Immunoglobulin E is not required for but enhances airway inflammation and hyperresponsiveness. Allergy 58 (2003) 1117-1124
28. Smith N., and Broadley K.J. Optimization of the sensitization conditions for an ovalbumin challenge model of asthma. Int Immunopharmacol 7 (2007) 183-190
29. Toward T.J., and Broadley K.J. Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin Exp Allergy 34 (2004) 91-102
30. Cieslewicz G., Tomkinson A., Adler A., Duez C., Schwarze J., Takeda K., et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 104 (1999) 301-308
31. Hopfenspirger M.T., and Agrawal D.K. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 168 (2002) 2516-2522
32. Karras J.G., McGraw K., McKay R.A., Cooper S.R., Lerner D., Lu T., et al. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 164 (2000) 5409-5415
33. Choi I.W., Sun K., Kim Y.S., Ko H.M., Im S.Y., Kim J.H., et al. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation. J Allergy Clin Immunol 116 (2005) 537-543
34. Koyama H., Tokuyama K., Nishimura H., Mizuno T., Mayuzumi H., Ohki Y., et al. Effect of disodium cromoglycate on airway mucus secretion during antigen-induced late asthmatic responses in a murine model of asthma. Int Arch Allergy Immunol 138 (2005) 189-196
35. Mayr S.I., Zuberi R.I., and Liu F.T. Role of immunoglobulin E and mast cells in murine models of asthma. Braz J Med Biol Res 36 (2003) 821-827
36. Fernandez-Rodriguez S., Broadley K.J., and Kidd E.J. Pharmacology of airway smooth muscle and cell influx in a murine asthma model. Eur Resp J 24 (2004) 690S
37. Buxco Research Systems. News: aerosol retrofit kit (2006). http://www.buxco.com/news.htm www.buxco.com/news.htm, accessed September 1 2006
38. Jang A.S., Choi I.S., Lee J.H., Park C.S., and Park C.S. Prolonged ozone exposure in a murine model of asthma: adaptation of airway responsiveness and airway remodeling. Respir Res 7 (2006) 24
39. Lee S.Y., Paik S.Y., and Chung S.M. Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma. J Microbiol 43 (2005) 11-16
40. Kobzik L., Goldsmith C.A., Ning Y.Y., Qin G., Morgan B., Imrich A., et al. Effects of combined ozone and air pollution particle exposure in mice. Res Rep Health Eff Inst 5-29 (2001) 31-38 discussion
41. Adler A., Cieslewicz G., and Irvin C.G. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 97 (2004) 286-292
42. Lundblad L.K.A., Irvin C.G., Adler A., and Bates J.H.T. A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol 93 (2002) 1198-1207
43. Archer A.J., Cramton J.L., Pfau J.C., Colasurdo G., and Holian A. Airway responsiveness after acute exposure to urban particulate matter 1648 in a DO11.10 murine model. Am J Physiol Lung Cell Mol Physiol 286 (2004) L337-L343
44. Dohi M., Tsukamoto S., Nagahori T., Shinagawa K., Saitoh K., Tanaka Y., et al. Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. Lab Invest 79 (1999) 1559-1571
45. Goldsmith C.A., Ning Y., Qin G., Imrich A., Lawrence J., Murthy G.G., et al. Combined air pollution particle and ozone exposure increases airway responsiveness in mice. Inhal Toxicol 14 (2002) 325-347
46. Mustafa S.J., Nadeem A., Fan M., Zhong H., Belardinelli L., and Zeng D. Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320 (2007) 1246-1251
47. Nadeem A., Fan M., Ansari H.R., Ledent C., and Mustafa S.J. Enhanced airway reactivity and inflammation in A2A adenosine receptor deficient allergic mice. Am J Physiol Lung Cell Mol Physiol 292 (2007) L1335-L1344
48. Xanthou G., Alissafi T., Semitekolou M., Simoes D.C., Economidou E., Gaga M., et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 13 (2007) 570-578
49. Zhou B., Comeau M.R., DE Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6 (2005) 1047-1053
50. Arvidsson M.B., Löwhagen O., and Rak S. Early and late phase asthmatic response in lower airways of cat-allergic asthmatic patients - a comparison between experimental and environmental allergen challenge. Allergy 62 (2007) 488-494
51. Gauvreau G.M., and Evans M.Y. Allergen inhalation challenge: a human model of asthma exacerbation. Contrib Microbiol 14 (2007) 21-32